Pfizer Inc. (NYSE:PFE) is one of the best wide moat stocks to buy now. On June 9, Pfizer, along with other drug manufacturers ...

Pfizer CEO Albert Bourla has pulled back the curtain on his $1.25 billion bet on a PD-1xVEGF bispecific, revealing that his ...

Pfizer (PFE) and other drugmakers met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Pfizer CEO Albert Bourla said on Monday at the Goldman Sachs ...

CEO Albert Bourla has reportedly said that the company has made no commitments during its meeting with the Trump ...

As President Donald Trump vows to bridge the drug pricing gap between the U.S. and other developed countries with his “most ...

Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no ...

Goldman Sachs 46th Annual Global Healthcare Conference June 9, 2025 8:00 AM ETCompany ParticipantsAlbert Bourla - Chairman of ...

Albert Bourla, who four years ago led Pfizer through its scientific and financial triumph during the covid-19 pandemic, is suddenly facing a new challenge from a large shareholder frustrated over ...

When a novel coronavirus struck in early 2020, Pfizer’sPFE1.22%increase; green up pointing triangle chief executive, Dr. Albert Bourla, saw an opportunity to help save the world. He pushed the ...

Albert Bourla said Pfizer is being "frugal" with investments because of the uncertainty surrounding tariffs.

Pfizer (NYSE:PFE) CEO Albert Bourla is expected to meet with activist investor Starboard Value next week after the activist accumulated a $1 billion stake in the pharma giant.

(Reuters) -Pfizer and other drug companies have met with the Trump administration to discuss lowering U.S. drug prices but no ...